NASDAQ:BFRA - BIOFRONTERA AG/ADR News Headlines

$14.48
0.00 (0.00 %)
(As of 08/20/2019 04:00 PM ET)
Today's Range
$14.4776
Now: $14.4776
$14.4776
50-Day Range
$14.38
MA: $15.84
$18.22
52-Week Range
$11.04
Now: $14.4776
$18.32
Volume1 shs
Average Volume228 shs
Market Capitalization$323.14 million
P/E RatioN/A
Dividend YieldN/A
Beta0.87

Headlines

BIOFRONTERA AG/ADR (NASDAQ BFRA) News Headlines

Source:
DateHeadline
BIOFRONTERA AG/ADR (BFRA) Set to Announce Earnings on TuesdayBIOFRONTERA AG/ADR (BFRA) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - August 20 at 2:20 AM
Biofrontera Announces Conference Call on August 27, 2019 to Discuss Half-year 2019 Financial ResultsBiofrontera Announces Conference Call on August 27, 2019 to Discuss Half-year 2019 Financial Results
finance.yahoo.com - August 14 at 11:00 AM
Biofrontera AG: Biofrontera provides update on Cutanea integrationBiofrontera AG: Biofrontera provides update on Cutanea integration
uk.finance.yahoo.com - August 5 at 4:08 PM
Biofrontera provides update on Cutanea integrationBiofrontera provides update on Cutanea integration
finance.yahoo.com - August 5 at 11:18 AM
Results of the voluntary partial tender offersResults of the voluntary partial tender offers
finance.yahoo.com - July 24 at 9:02 AM
Annual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majorityAnnual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majority
finance.yahoo.com - July 11 at 10:51 AM
Thomas SchafferThomas Schaffer
www.benzinga.com - June 25 at 8:02 AM
Biofronteras CFO On The Dermatology Biotechs Pipeline, Growth, Acquisitions And MoreBiofrontera's CFO On The Dermatology Biotech's Pipeline, Growth, Acquisitions And More
www.benzinga.com - June 24 at 7:35 PM
Biofrontera board members back partial tender offerBiofrontera board members back partial tender offer
seekingalpha.com - June 21 at 9:14 AM
All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their sharesAll Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares
finance.yahoo.com - June 21 at 9:14 AM
Biofrontera to Present at Two Upcoming Investor ConferencesBiofrontera to Present at Two Upcoming Investor Conferences
finance.yahoo.com - June 13 at 7:47 AM
Biofrontera: The Battle For OwnershipBiofrontera: The Battle For Ownership
seekingalpha.com - June 11 at 3:54 PM
Biofrontera: Takeover Battle In Sight?Biofrontera: Takeover Battle In Sight?
seekingalpha.com - June 11 at 12:02 PM
Biofrontera nominates new candidate for the Supervisory BoardBiofrontera nominates new candidate for the Supervisory Board
finance.yahoo.com - June 4 at 11:49 AM
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q1 2019 Results - Earnings Call TranscriptBiofrontera AG (BFRA) CEO Hermann Lübbert on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 29 at 4:04 PM
Biofrontera AG to Host Earnings CallBiofrontera AG to Host Earnings Call
finance.yahoo.com - May 29 at 4:04 PM
Biofrontera AG ADRBiofrontera AG ADR
www.barrons.com - May 24 at 11:42 AM
Biofrontera Announces Conference Call on May 29, 2019 to Discuss First Quarter 2019 Financial ResultsBiofrontera Announces Conference Call on May 29, 2019 to Discuss First Quarter 2019 Financial Results
finance.yahoo.com - May 16 at 9:12 AM
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2018 Results - Earnings Call TranscriptBiofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - April 29 at 3:56 PM
Biofrontera Reports Full Year 2018 Financial ResultsBiofrontera Reports Full Year 2018 Financial Results
finance.yahoo.com - April 29 at 11:27 AM
Biofrontera AG to hold extraordinary shareholders’ meeting on 15 May 2019Biofrontera AG to hold extraordinary shareholders’ meeting on 15 May 2019
finance.yahoo.com - April 26 at 11:32 AM
Biofrontera on go with Ameluz marketing applications in Q3Biofrontera on go with Ameluz marketing applications in Q3
seekingalpha.com - April 16 at 1:25 PM
Biofrontera Announces Conference Call on April 29, 2019 to Discuss 2018 Financial ResultsBiofrontera Announces Conference Call on April 29, 2019 to Discuss 2018 Financial Results
finance.yahoo.com - April 16 at 1:25 PM
Biofrontera reports further positive results from the phase III trial with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neckBiofrontera reports further positive results from the phase III trial with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck
finance.yahoo.com - April 16 at 1:25 PM
Biofrontera announces interim Q1 salesBiofrontera announces interim Q1 sales
seekingalpha.com - April 15 at 4:05 PM
Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019
finance.yahoo.com - April 15 at 9:02 AM
European ADRs in Tuesday TradingEuropean ADRs in Tuesday Trading
www.nasdaq.com - April 2 at 11:40 AM
Biofrontera provides information on the announced voluntary public tender offer by Maruho Deutschland GmbHBiofrontera provides information on the announced voluntary public tender offer by Maruho Deutschland GmbH
finance.yahoo.com - April 2 at 11:40 AM
Changes in the composition of the Supervisory BoardChanges in the composition of the Supervisory Board
finance.yahoo.com - March 27 at 12:41 PM
Biofrontera +2% on acquisition of Cutanea Life SciencesBiofrontera +2% on acquisition of Cutanea Life Sciences
seekingalpha.com - March 25 at 12:00 PM
Biofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USABiofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USA
finance.yahoo.com - March 25 at 12:00 PM
Biofrontera provides corporate update; conference call details for March 26, 2019Biofrontera provides corporate update; conference call details for March 26, 2019
finance.yahoo.com - March 25 at 12:00 PM
Biofrontera Reports Positive Phase III Results with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neckBiofrontera Reports Positive Phase III Results with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck
finance.yahoo.com - March 20 at 11:30 AM
Biofrontera AG and Maruho Co., Ltd. conclude cooperation agreement regarding branded generics and plan collaboration on expansion of indications and distribution of Ameluz®Biofrontera AG and Maruho Co., Ltd. conclude cooperation agreement regarding branded generics and plan collaboration on expansion of indications and distribution of Ameluz®
finance.yahoo.com - March 19 at 11:49 AM
Biofrontera AG Estimate MomentumBiofrontera AG Estimate Momentum
www.nasdaq.com - March 18 at 4:14 PM
Biofrontera Honored with Prestigious Silver Stevie(R) Award for Outstanding U.S. Customer Service Department of the YearBiofrontera Honored with Prestigious Silver Stevie(R) Award for Outstanding U.S. Customer Service Department of the Year
finance.yahoo.com - February 25 at 11:23 AM
Biofrontera implements new Falsified Medicines DirectiveBiofrontera implements new Falsified Medicines Directive
finance.yahoo.com - February 11 at 3:53 PM
Biofrontera announces preliminary unaudited sales revenue and updates consolidated net income guidance for the full year 2018Biofrontera announces preliminary unaudited sales revenue and updates consolidated net income guidance for the full year 2018
finance.yahoo.com - January 22 at 3:49 PM
Biofrontera receives FDA approval for upscaling of batch size for Ameluz® productionBiofrontera receives FDA approval for upscaling of batch size for Ameluz® production
finance.yahoo.com - January 8 at 11:09 AM
European ADRs Move Sharply Higher in Friday TradingEuropean ADRs Move Sharply Higher in Friday Trading
www.nasdaq.com - January 4 at 3:36 PM
Ruling by the U.S. District Court of MassachussettsRuling by the U.S. District Court of Massachussetts
finance.yahoo.com - December 27 at 3:31 PM
Biofrontera: Ameluz - The Key Future Value DriverBiofrontera: Ameluz - The Key Future Value Driver
seekingalpha.com - November 27 at 11:29 AM
Form 6-K Biofrontera AG For: Nov 26Form 6-K Biofrontera AG For: Nov 26
www.streetinsider.com - November 26 at 3:28 PM
Biofrontera to Participate in Two Upcoming Investor ConferencesBiofrontera to Participate in Two Upcoming Investor Conferences
finance.yahoo.com - November 26 at 3:28 PM
Biofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2018 Results - Earnings Call TranscriptBiofrontera AG (BFRA) CEO Hermann Lübbert on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 16 at 3:28 PM
Biofrontera reports earnings results for the third quarter and first nine months of 2018Biofrontera reports earnings results for the third quarter and first nine months of 2018
finance.yahoo.com - November 16 at 10:22 AM
Biofrontera Announces Conference Call to Discuss Q3 2018 Financial ResultsBiofrontera Announces Conference Call to Discuss Q3 2018 Financial Results
finance.yahoo.com - November 5 at 8:42 AM
Biofrontera to Present at the 4th Annual Dawson James Small Cap Growth Stock ConferenceBiofrontera to Present at the 4th Annual Dawson James Small Cap Growth Stock Conference
finance.yahoo.com - October 15 at 9:42 AM
Biofrontera announces preliminary unaudited sales revenue for the first nine months of 2018 and increases revenue guidanceBiofrontera announces preliminary unaudited sales revenue for the first nine months of 2018 and increases revenue guidance
finance.yahoo.com - October 10 at 9:32 AM
Form 6-K Biofrontera AG For: Oct 01Form 6-K Biofrontera AG For: Oct 01
www.streetinsider.com - October 1 at 3:23 PM
This page was last updated on 8/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel